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Abstract
The completion and opening of a commercial FDG produc-
tion facility at the Rudjer Boskovic Institute, Zagreb, Croatia 
ensured a continuous, reliable daily supply of radioactive 
compound on site. This has laid the foundations for estab-
lishing a centre for nuclear molecular diagnostics which 
initially uses already available FDG, but later we also plan to 
synthesise other F18 radiopharmaceuticals. In the long run 
it is anticipated that we shall expand our activities to other 
positron-emission isotopes like C11. A ClearPet camera has 
been purchased, delivered, tested and correlated with PMOD 
image analysis software. We report on the present operational 
status of the facility, we show the first preliminary results, and 
offer our projections for further development in the scientific 
and organisational sense. The final aim of this facility is to 
grow into a strong research centre with good scientific col-
laboration with other R&D organisations in the region. 
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Existing infrastructural advantages
Availability of radioisotopes and FDG 
radiopharmaceutical
Commissioning the new 18 MeV Cyclone 18/9 HC pro-
ton cyclotron, located at the site of the Institute, and setting 
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up the whole chain of GMP production of fludeoxyglocose 
(FDG) for supplying the daily needs of Croatian hospitals in 
the form of the Rudjer Medikol Cyclotron (RMC) company, 
the RBI has gained the opportunity of preferred, regular and 
daily use of the radioisotopes produced, but also the use of 
the cyclotron in time not intended for commercial production. 
The scheme of the existing facility and the planned extension 
are shown in Figure 1. 
As the availability of radiopharmaceuticals is a conditio sine 
qua non of each PET diagnostic procedure, this has opened 
the possibility to enter new areas of scientific research in 
physics, chemistry and bio-medicine based on using nuclear 
molecular diagnostics techniques in small animals. Because of 
daily medical routines in Croatian hospitals the FDG is reliably 
produced each morning, and the small quantity needed for 
experimental PET can be spared with almost no extra costs. 
The continuity of the radio-production procedures, qualified 
operating personnel and above all regular maintenance of the 
nuclear and radio-chemical part is guaranteed by the com-
mercial aspect of the undertaking. 
Animal facility
A second conditio sine qua non of PET diagnostics is the 
availability of experimental animals and the legal permission 
to perform in vivo experiments. The Rudjer Boskovic Institute 
has a well established animal facility which breeds inbred strains of 
mice [BALB/cBkl, CBA/H, C3Hf/Bu, C57BL/Go, C57BL/6-Ly5, 
NOD, Hsd:ICR (CD-1)] for research projects conducted mainly 
at the Rudjer Boskovic Institute. In our animal unit two colonies of 
rats have been developed from the Wistar stock, i.e. “Hypersero-
toninemic rat” and “Wistar-Zagreb 5HT rat”. Both types are used in 
neuroscience research as rodent models for selected neuropsychi-
atric disorders as well as in related neuro-psycho-pharmacological 
research.
Scientific interest
As the RBI is a multidisciplinary institute a number of 
bio-medical research projects are in progress, so the main 
task of the future PET centre is not only to develop and accept 
PET research techniques, but above all to make them known 
to an environment where there is no active knowledge about 
their comprehensiveness and potential. Therefore, one of our 
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main tasks is not only technical development; we have to devote 
a significant part of our time to teaching our colleagues and 
spreading knowledge about PET methods. Up to now we have 
developed notable interest of our colleagues in research on 
diabetes, research on tumour diseases and oxidative stress. 
We have also attracted the attention of our colleagues from the 
Croatian Institute for Brain Research (CIBR) and the University 
of Zagreb School of Medicine (SM). With CIBR we have started 
research on FDG distribution of ischemic brain insult in mice, 
and with SM we have initiated the study of FGD distribution of 
ischemic heart insult in rats. 
Mission
The mission of the new PET centre is to perform basic 
research in biomedicine, radiochemistry and physics: 1. inves-
tigating metabolic spread of bioactive substances in vivo; 2. the 
dynamics of the interaction of bioactive substances with healthy 
and tumorous tissue; 3. the follow up of tumour growth in animal 
models in vivo; 4. the follow up of normal and pathological meta-
bolic processes in living organisms (diabetes, neurological disor-
ders...); 5. the development of new radiopharmaceuticals based 
on 18F; 6. the development of new radiopharmaceuticals based 
on other radioisotopes; 7. offering PET services to external us-
ers on a commercial basis.
Vision
To create a regional centre of excellence for basic research 
based on nuclear molecular diagnostics.
To create a regional centre offering PET services on a com-
mercial basis.
Strategy
1. To purchase the basic equipment for acquiring PET images.
2. To set up (assemble) the whole experimental chain from iso-
tope to image interpretation shown in Figure 2 with minimal 
additional investments to gain experience.
3. To demonstrate the ability to run the experimental chain.
4. Identify weaknesses.
5. Find financing to improve the weak links.
6. Improve the weak links.
7. Strengthen the research team through local work and inter-
national collaborations.
Equipment purchased 
We have purchased a ClearPet camera by Raytest, with a mini-
mal configuration of 8 out of 20 possible cassettes, and PMOD 
software for image analysis. The characteristics of the system and 
actual photographs are given in Figure 3. 
We have performed experiments under minimal biological 
conditions (Table 1).
Status and results
The experimental system is harmonised, streamlined, tested 
and standardised. 
We have performed over 140 successful in vivo experiments on 
various inbred strains of mice with the aim of defining the scope, 
significance and potential of new PET techniques in research 
on: tumorous diseases, diabetes, metabolic disorders (oxidative 
stress), neurological disorders (ischemic brain insult) and cardiac 
disorders (ischemic cardiac insult). Typical results are shown in 
Figure 4. 
Figure 1. The existing facility and planned extension of RBI PET 
Center
Table 1.
Rohbau non-clasified space Instead of Class C laboratory
IP anesthesia Instead of Isoflourane gasseous anesthesia
IP isotope administration Instead of IV isotope administration  
Heating with warm air Instead of Heating pads with automathic temp. control
Animal tumors Instead of Human tumors
Basic vantilation, no temp. and humidity control Instead of Full HVAC
Basic radioprotection Instead of Full radioprotection
No radiochemistry lab Instead of Full radiochemistry lab
Only 18F-FDG Instead of 18F + different ligands
Only 18F Instead of At lest 11C in addition  
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Figure 2. Experimental chain of PET diagnostics
Figure 3. The minimal PET system purchased
Figure 4. Typical experimental results of the current configuration
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At the moment we can with certainty follow qualitative and 
quantitative distribution of FDG radiopharmaceutical:
·  in time intervals of 2 minutes;
·  in a grid of 1.15 mm ´ 1.15 mm ´ 1.15 mm;
·  with an estimated precision of ± 20 %;
·  filter, smooth and average the data obtained;
·  make a 2D numerical analysis of the images obtained with 
predefined or manually drawn volumes of interest (VOI);
·  make a 3D reconstruction of the images obtained;
·  make a corregistration of our images with a given input file 
from other machines:
 — as a routine we make a corregistration of our images with 
a CT mouse template obtained from PMOD,
 — as a routine we make a corregistration of our images with 
MR mouse templates obtained from PMOD,
 — we can use mouse brain VOI templates from the Mirrione 
mouse atlas and numerically evaluate our results,
 — we can rescale and move in 3D space each individual 
VOI from the Mirrione mouse atlas and adjust it to fit our 
particular animal.
However, seemingly identical biological initial conditions give 
rather different biological uptake.
